<DOC>
	<DOCNO>NCT01237535</DOCNO>
	<brief_summary>This single center , 3 arm , prospective randomize control open study determine impact luteal phase support pregnancy rate ovarian stimulation IUI cycle recombinant FSH patient unexplained infertility mild male factor . Patients randomize 3 group : 1 . Luteal support progesterone ( receive vaginal P gel ( Crinone 8 % vaginal gel ; Serono , Israel ) 2 . Luteal support estrogen + progesterone [ ( Crinone 8 % vaginal gel ; Serono , Israel ) Estrofem 4mg ] . 3 . No luteal support</brief_summary>
	<brief_title>Luteal Phase Support With Progesterone Versus Estrogen Progesterone Pregnancy Rates</brief_title>
	<detailed_description>Study design : single center , 3 arm , prospective randomize control open study Objective : determine impact luteal phase support pregnancy rate ovarian stimulation IUI cycle recombinant FSH patient unexplained infertility mild male factor . Methods : All patient study group undergo single insemination procedure randomize 3 group : 1 . Luteal support progesterone ( receive vaginal P gel ( Crinone 8 % vaginal gel ; Serono , Israel ) 2 . Luteal support estrogen + progesterone [ ( Crinone 8 % vaginal gel ; Serono , Israel ) Estrofem 4mg ] . 3 . No luteal support Luteal support begin insemination continue 12th week gestation patient conceive . A pregnancy test perform 2 week insemination ( Serum hCG ) intrauterine pregnancy confirm use transvaginal ultrasound 2 week positive pregnancy test . If pregnancy achieve patient undergo 3 treatment cycle preferably treatment group .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>1 . Couples diagnosis unexplained infertility 2 . In treatment cycle ovarian stimulation IUI use recombinant FSH institution . 1. female partner one following : previous ovarian surgery one ovary polycystic ovary ultrasound examination endocrine abnormality ( i.e. , polycystic ovarian syndrome , thyroid disorder , hyperprolactinemia,6.hypogonadotropic hypogonadism ) past ovarian hyperstimulation hyperstimulation study period diminish ovarian reserve ( basal FSH level &gt; 15 IU/mL ) age &gt; 40 year 2. sever male factor &lt; 5 million total motile sperm day insemination .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Unexplained infertility</keyword>
	<keyword>Insemination</keyword>
	<keyword>Luteal phase support</keyword>
	<keyword>Ovarian stimulation</keyword>
</DOC>